Lianqin Sun

463 citations
16 papers · 135 indexed · h-index 7
Topics
Renal Diseases and Glomerulopathies (8 papers)Chronic Kidney Disease and Diabetes (6 papers)Vasculitis and related conditions (3 papers)
Partner nations
ChinaUnited States

In The Last Decade

Lianqin Sun

16 papers receiving 135 citations

Peers

Lianqin Sun
Comparison fields: 5 of 45
  • Nephrology 79
  • Pathology and Forensic Medicine 20
  • Oncology 20
  • Molecular Biology 19
  • Surgery 19
Replace Diana Moldovan with:
Diana Moldovan Romania
Cindy X. Cai United States
Ricong Xu China
Hermann-Josef Groene Germany
Karen L. Onions United Kingdom
Takashi Yokoo Japan
Frank Joseph United Kingdom
Ban Zhao China
Lidia V. Lysenko Russia
Shuqin Xie China
Lianqin Sun relative to Diana Moldovan Romania Diana Moldovan's profile →
Citations per field
00.5×
Diana Moldovan · 1×
Citations per year

Countries citing papers authored by Lianqin Sun

Since Specialization
Citations

This map shows the geographic impact of Lianqin Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianqin Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianqin Sun more than expected).

Fields of papers citing papers by Lianqin Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lianqin Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianqin Sun. The network helps show where Lianqin Sun may publish in the future.

Co-authorship network of co-authors of Lianqin Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Lianqin Sun. A scholar is included among the top collaborators of Lianqin Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianqin Sun. Lianqin Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 4
2 11
3 3
4 5
5 5
6 10
7 3
8 1
9 24
10 6
11 2
12 27
13 22
14 5
15 1
16
[Effects of Jinmaitong capsule on nerve growth factor in diabetic rats].
6

About Lianqin Sun

Lianqin Sun is a scholar working on Nephrology, Transplantation and Pathology and Forensic Medicine, having authored 16 papers that have together received 135 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (8 papers), Chronic Kidney Disease and Diabetes (6 papers) and Vasculitis and related conditions (3 papers). The work is most often cited by research in Nephrology (79 citations), Clinical Biochemistry (10 citations) and Pathology and Forensic Medicine (20 citations). Lianqin Sun has collaborated with scholars based in China and United States. Frequent co-authors include Yanggang Yuan, Changying Xing, Bo Zhang, Chengning Zhang, Suyan Duan, Zhimin Huang, Lin Wu, Huanhuan Zhu, Zhimin Huang and Lin Wu. Their work appears in journals such as Kidney International, Journal of the American Society of Nephrology and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026